Actigraphic monitoring of sleep and circadian rest-activity rhythm in individuals with major depressive disorder or depressive symptoms: A meta-analysis

Background: Disrupted sleep and rest -activity pattern are common clinical features in depressed individuals. This meta -analysis compared sleep and circadian rest -activity rhythms in people with major depressive disorder (MDD) or depressive symptoms and healthy controls. Methods: Eligible studies were identified in five databases up to December 2023. The search yielded 53 studies with a total of 11,115 participants, including 4000 depressed participants and 7115 healthy controls. Results: Pooled meta -analyses demonstrated that depressed individuals have significantly longer sleep latency (SMD = 0.23, 95 % CI: 0.12 to 0.33) and wake time after sleep onset (SMD = 0.37, 95 % CI: 0.22 to 0.52), lower sleep efficiency (SMD = -0.41, 95 % CI: -0.56 to -0.25), more nocturnal awakenings (SMD = 0.58, 95 % CI: 0.29 to 0.88), lower MESOR (SMD = -0.54, 95 % CI: -0.81 to -0.28), amplitude (SMD = -0.33, 95 % CI: -0.57 to -0.09), and interdaily stability (SMD = -0.17, 95 % CI: -0.28 to -0.05), less daytime (SMD = -0.79, 95 % CI: -1.08 to -0.49) and total activities (SMD = -0.89, 95 % CI: -1.28 to -0.50) when compared with healthy controls. Limitations: Most of the included studies reported separate sleep and activity parameters instead of 24 -hour restactivity rhythms. The variabilities among actigraphy devices and the types of participants recruited also impede precise comparisons. Conclusions: The findings emerging from this study offered a better understanding of sleep and rest -activity rhythm in individuals with MDD or depressive symptoms. Future studies could advocate for deriving objective, distinctive 24 -hour rest -activity profiles contributing to the risk of depression. PROSPERO registration number: CRD42021259780.